Literature DB >> 11264358

Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.

D Lavillette1, B Boson, S J Russell, F L Cosset.   

Abstract

Cell entry of retroviruses is initiated by the recognition of cellular receptors and the subsequent membrane fusion between viral and cellular membranes. These two steps are mediated by the surface (SU) and transmembrane (TM) subunits of the retroviral envelope glycoprotein (Env), respectively. Determinants regulating membrane fusion have been described throughout SU and TM, but the processes coupling receptor recognition to fusion are still elusive. Here we establish that a critical interaction is formed between the receptor-binding domain (RBD) and the major disulfide loop of the carboxy-terminal domain (C domain) of the murine leukemia virus SU. Receptor binding causes an alteration of this interaction and, in turn, promotes further events of Env fusion activation. We characterize mutations which, by lowering this interaction and reducing the compatibility between the RBD and C domains of Env glycoprotein chimeras, affect both Env fusogenicity and sensitivity to receptor interference. Additionally, we demonstrate that suboptimal interactions in such mutant Env proteins can be compensated in trans by soluble RBDs in a manner that depends on their compatibility with the C domain. Our results therefore indicate that RBD/C domain interactions may occur in cis, via the proper RBD of the viral Env itself, or in trans, via a distinct RBD expressed by virion-free Env glycoproteins expressed endogenously by the infected cells or provided by neighboring Env trimers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264358      PMCID: PMC114860          DOI: 10.1128/JVI.75.8.3685-3695.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Turning a corner on HIV neutralization?

Authors:  J H Nunberg; K E Follis; M Trahey; R A LaCasse
Journal:  Microbes Infect       Date:  2000-02       Impact factor: 2.700

2.  Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency.

Authors:  J H Slingsby; D Baban; J Sutton; M Esapa; T Price; S M Kingsman; A J Kingsman; A Slade
Journal:  Hum Gene Ther       Date:  2000-07-01       Impact factor: 5.695

3.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Lipids and cell fusion in vitro: effect of amphotericin B.

Authors:  T Kataoka; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

5.  Expression of endogenous ALV antigens and susceptibility to subgroup E ALV in three strains of chickens (endogenous avian C-type virus).

Authors:  H L Robinson; W F Lamoreux
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

6.  Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.

Authors:  Z Jobbagy; S Garfield; L Baptiste; M V Eiden; W B Anderson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Characteristics of Sendai virus receptors in a model membrane.

Authors:  A M Haywood
Journal:  J Mol Biol       Date:  1974-03-15       Impact factor: 5.469

Review 8.  Virus receptors: binding, adhesion strengthening, and changes in viral structure.

Authors:  A M Haywood
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.

Authors:  T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  Identification of a cellular cofactor required for infection by feline leukemia virus.

Authors:  M M Anderson; A S Lauring; C C Burns; J Overbaugh
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

View more
  42 in total

Review 1.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

2.  A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses.

Authors:  David L Wensel; Weihua Li; James M Cunningham
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein.

Authors:  Chi-Wei Lu; Monica J Roth
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering.

Authors:  Robin Löving; Shang-Rung Wu; Mathilda Sjöberg; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

6.  Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

Authors:  Heather H Cheng; Maria M Anderson; F Claire Hankenson; Lily Johnston; Chitra V Kotwaliwale; Julie Overbaugh
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.

Authors:  J Sugai; M Eiden; M M Anderson; N Van Hoeven; C D Meiering; J Overbaugh
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells.

Authors:  V Solodushko; B Fouty
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.